DK1377550T3 - Phenyl heterocyclylate derivatives as serotonin re-uptake inhibitors - Google Patents

Phenyl heterocyclylate derivatives as serotonin re-uptake inhibitors

Info

Publication number
DK1377550T3
DK1377550T3 DK02713129T DK02713129T DK1377550T3 DK 1377550 T3 DK1377550 T3 DK 1377550T3 DK 02713129 T DK02713129 T DK 02713129T DK 02713129 T DK02713129 T DK 02713129T DK 1377550 T3 DK1377550 T3 DK 1377550T3
Authority
DK
Denmark
Prior art keywords
heterocyclylate
serotonin
phenyl
derivatives
uptake inhibitors
Prior art date
Application number
DK02713129T
Other languages
Danish (da)
Inventor
Mavis Diane Adam
Mark David Andrews
Geoffrey Edward Gymer
David Hepworth
Harry Ralph Howard
Donald Stuart Middleton
A Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/IB2002/001032 external-priority patent/WO2002083643A1/en
Application granted granted Critical
Publication of DK1377550T3 publication Critical patent/DK1377550T3/en

Links

DK02713129T 2002-03-27 2002-03-27 Phenyl heterocyclylate derivatives as serotonin re-uptake inhibitors DK1377550T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/001032 WO2002083643A1 (en) 2001-04-11 2002-03-27 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors

Publications (1)

Publication Number Publication Date
DK1377550T3 true DK1377550T3 (en) 2005-02-07

Family

ID=34113355

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02713129T DK1377550T3 (en) 2002-03-27 2002-03-27 Phenyl heterocyclylate derivatives as serotonin re-uptake inhibitors

Country Status (1)

Country Link
DK (1) DK1377550T3 (en)

Similar Documents

Publication Publication Date Title
DK1749818T3 (en) Phenylpiperidine derivatives as serotonin reuptake inhibitors
NO20044654L (en) Piperidinoylpiperidines as 5-HTIF agonists
DK1585749T3 (en) Diazepinoindole derivatives as kinase inhibitors
DK1789041T3 (en) Aryl-pyridine derivatives as 11-beta-HSD1 inhibitors
NO20034307L (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
DK1797042T3 (en) Indozolone derivatives as 11B-HSD1 inhibitors
DK1492785T3 (en) 2-hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors
DK2039685T3 (en) Heterobicyclic Compounds as P38 Inhibitors
NO20050665L (en) Pyrrolidone derivatives as MAOE inhibitors
NO20055680D0 (en) Hexahydropyridoisoquinolines as DPP-IV inhibitors
DK1848430T3 (en) NEW BENZYLAMINE DERIVATIVES AS CETP INHIBITORS
DK1501826T3 (en) Substituted indoles as alpha-1 agonists
DK2130537T3 (en) N3-alkylated benzimidazole derivatives as MEK inhibitors
DK1603570T3 (en) AMINOHETEROARYL COMPOUNDS AS PROTEINKINASE INHIBITORS
DK1586319T3 (en) Thiadiazolidinones as GSK-3 inhibitors
DK1959951T3 (en) Heteroberl-substituted piperidine derivatives as L-CPT1 inhibitors
NO20050426L (en) Arylcarbonyl derivatives as therapeutic agents
IS2656B (en) New besimidasol derivatives
DK1699797T3 (en) Pyrrolotriazine Compounds as Kinase Inhibitors
DK1638933T3 (en) N-pyrrolidin-3-yl amide derivatives as serotonin and noradrenaline reuptake inhibitors
DK1660090T3 (en) QUINAZOLINE ANALOGS AS RECEPTOR-TYROSINKINASE INHIBITORS
DK1633712T3 (en) Six linked amino-amide derivatives as angiogenesis inhibitors
DK1438289T3 (en) Indole derivatives as cox II inhibitors
DK1556377T3 (en) Cyclopropylthienylcarboxamides as fungicides
NO20034525D0 (en) Phenyl heterocyclyl ether derivatives such as serotonin reuptake inhibitors